{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T19:16:29Z","timestamp":1772565389836,"version":"3.50.1"},"reference-count":64,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"1","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Glob Oncol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>PURPOSE<\/jats:title>\n                    <jats:p>Cancer burden in sub-Saharan Africa is high, driven by infections and behavioral risks. Nigeria had Africa's second-highest number of new cancers in 2022. This study estimated the proportion of new cancers attributable to alcohol, tobacco, and human papillomavirus (HPV) infection in Edo State, Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>We analyzed cancer incidence data from the Edo-Benin Cancer Registry (EBCR; 2009-2018) for cancer sites associated with alcohol consumption, tobacco use, and HPV infection, as outlined in the International Agency for Research on Cancer Monographs. For each site, we calculated the number of attributable cancers and the population attributable fraction for the three exposures by sex, using country-specific exposure prevalence and relative risk estimates from previous research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Between 2009 and 2018, the EBCR reported 4,937 cancer cases (2,069 men [41.9%] and 2,868 women [58.1%]). Nine alcohol-associated sites accounted for 30.1% of all cases (12.3% in men and 43% in women), 13 tobacco-related sites accounted for 27.5% (18.4% in men and 34.1% in women), and six HPV-related sites accounted for 15.2% (4% in men and 34.1% in women). Of alcohol-associated cancers (n = 1,488), 25.6% (381\/1,488) were attributable to alcohol use; 5.3% (72\/1,359) of smoking-related cancers were attributable to tobacco use, and high-risk HPV genotypes were estimated to cause 77.5% (581\/750) of HPV-related cancers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Our study suggests that nearly three fourths of HPV- and about one fourth of alcohol-associated cancers could be prevented through targeted and evidence-based interventions in Edo State, Nigeria. These findings highlight the need for strengthening both individual and policy-level prevention efforts, prioritizing high-impact risk factors to achieve measurable reductions in cancer burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/go-25-00318","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:58:08Z","timestamp":1768510688000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":0,"title":["Estimation of New Cancers Attributable to Alcohol, Tobacco, and Human Papillomavirus Infection in Edo State, Nigeria"],"prefix":"10.1200","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2839-4529","authenticated-orcid":true,"given":"Agbonvihele Gregrey","family":"Oko-Oboh","sequence":"first","affiliation":[{"name":"Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[{"name":"Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland"},{"name":"Prostate Cancer Research Center, Tampere University, Tampere, Finland"},{"name":"Fi-Can Mid Regional Cancer Center, Tampere University, Tampere, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8222-1592","authenticated-orcid":true,"given":"Darlington Ewaen","family":"Obaseki","sequence":"additional","affiliation":[{"name":"Histopathology Department, University of Benin, Benin, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-6673","authenticated-orcid":true,"given":"Janne","family":"Pitk\u00e4niemi","sequence":"additional","affiliation":[{"name":"Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland"},{"name":"Finnish Cancer Registry, Helsinki, Finland"},{"name":"University of Helsinki, Department of Public Health, Helsinki, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1032749"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00720-8"},{"key":"e_1_3_4_4_2","article-title":"Cancer care gap: Examining cancer mortality-incidence rate ratio in sub-Saharan Africa","author":"Lawa QO","unstructured":"Lawa QO, Lawal I, Eigbefoh J, et al: Cancer care gap: Examining cancer mortality-incidence rate ratio in sub-Saharan Africa. JCO Glob Oncol 10.1200\/GO-24-00383","journal-title":"JCO Glob Oncol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1001\/jama.2022.10019","article-title":"Cancer deaths may double by 2030 in sub-Saharan Africa","volume":"327","author":"Larkin HD","year":"2022","unstructured":"Larkin HD: Cancer deaths may double by 2030 in sub-Saharan Africa. JAMA 327:2280, 2022","journal-title":"JAMA"},{"key":"e_1_3_4_6_2","volume-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","author":"International Agency for Research on Cancer","year":"2009","unstructured":"International Agency for Research on Cancer: A review of human carcinogens. Part B: Biological agents, in IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 2009. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Biological-Agents-2012"},{"key":"e_1_3_4_7_2","volume-title":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","author":"International Agency for Research on Cancer","year":"2012","unstructured":"International Agency for Research on Cancer: A review of human carcinogens. Part E: Personal habits and indoor combustions, IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, France, 2012. https:\/\/publications.iarc.fr\/Book-And-Report-Series\/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans\/Personal-Habits-And-Indoor-Combustions-2012"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00279-5"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4647"},{"key":"e_1_3_4_10_2","first-page":"48","volume-title":"Global Cancer Facts & Figures","author":"American Cancer Society","year":"2024","unstructured":"American Cancer Society: Global Cancer Facts & Figures (ed 5), 2024, p 48","edition":"5"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-082492"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00183"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2016.10.008"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-8010-8"},{"key":"e_1_3_4_15_2","volume-title":"ICF: Nigeria Demographic and Health Survey 2018","author":"National Population Commission (NPC), Nigeria","year":"2019","unstructured":"National Population Commission (NPC), Nigeria: ICF: Nigeria Demographic and Health Survey 2018, 2019. https:\/\/www.dhsprogram.com\/pubs\/pdf\/FR359\/FR359.pdf"},{"key":"e_1_3_4_16_2","volume-title":"ICF International: Nigeria Demographic and Health Survey 2013","author":"National Population Commission (NPC), Nigeria","year":"2014","unstructured":"National Population Commission (NPC), Nigeria: ICF International: Nigeria Demographic and Health Survey 2013, 2014. https:\/\/www.dhsprogram.com\/pubs\/pdf\/FR293\/FR293.pdf"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1938201"},{"key":"e_1_3_4_18_2","volume-title":"Cancer Registry\u2014UBTH","author":"UBTH","year":"2022","unstructured":"UBTH: Cancer Registry\u2014UBTH, 2022. https:\/\/ubth.org\/cancer%20registry\/#"},{"key":"e_1_3_4_19_2","volume-title":"2006 Population And Housing Census of the Federal Republic of Nigeria, Priority Tables, Volume I","author":"National Population Commission (NPC)","year":"2010","unstructured":"National Population Commission (NPC): 2006 Population And Housing Census of the Federal Republic of Nigeria, Priority Tables, Volume I, 2010. https:\/\/nationalpopulation.gov.ng\/category\/publications\/"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21903"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gloepi.2021.100062"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.579"},{"key":"e_1_3_4_23_2","volume-title":"Human Papillomaviruses","author":"International Agency for Research on Cancer","year":"1995","unstructured":"International Agency for Research on Cancer: IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Studies of Cancer in Humans, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 64, in Human Papillomaviruses. Lyon, France, International Agency for Research on Cancer, 1995"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","unstructured":"Ferguson J O'Connell M: graphPAF: An R package to estimate and display population attributable fractions. CRAN 2023. https:\/\/api.semanticscholar.org\/CorpusID:259281038","DOI":"10.32614\/CRAN.package.graphPAF"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-024-01129-1"},{"key":"e_1_3_4_26_2","unstructured":"National Population Commission (NPC) Nigeria: ICF macro: Nigeria demographic and health survey 2008 2009. https:\/\/www.dhsprogram.com\/pubs\/pdf\/fr222\/fr222.pdf"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2019.1628244"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-024-17972-6"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30716"},{"key":"e_1_3_4_30_2","first-page":"a8304","article-title":"Alcohol abuse in African traditional religion: Education and enlightenment as panacea for integration and development","volume":"79","author":"Ekeke EC","year":"2023","unstructured":"Ekeke EC, John EO: Alcohol abuse in African traditional religion: Education and enlightenment as panacea for integration and development. HTS Teol Stud 79:a8304, 2023","journal-title":"HTS Teol Stud"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/13607804221133118"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/009145090903600107"},{"key":"e_1_3_4_33_2","unstructured":"Nsidibe-Abasi JU Edozie C: Alcohol-policy-brief: Tackling harmful alcohol consumption in Nigeria. https:\/\/gatefield.co\/wp-content\/uploads\/2023\/11\/Alcohol-Policy-Brief.pdf"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7139-9"},{"key":"e_1_3_4_35_2","unstructured":"World Health Organization: Global status report on alcohol and health and treatment of substance use disorders 2024. https:\/\/iris.who.int\/bitstream\/handle\/10665\/377960\/9789240096745-eng.pdf?sequence=1"},{"key":"e_1_3_4_36_2","first-page":"89","article-title":"Estimated prevalence of human papillomavirus among Nigerian women: A systematic review and meta-analysis","volume":"26","author":"Anoruo O","year":"2022","unstructured":"Anoruo O, Bristow C, Mody N, et al: Estimated prevalence of human papillomavirus among Nigerian women: A systematic review and meta-analysis. Afr J Reprod Health 26:89-96, 2022","journal-title":"Afr J Reprod Health"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1254304"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2013-051456"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231182884"},{"key":"e_1_3_4_40_2","first-page":"e01013","article-title":"Knowledge, attitudes, and perceptions about cervical cancer, and the uptake of cervical cancer screening in Nigeria: An integrative review","volume":"14","author":"Uchendu I","year":"2021","unstructured":"Uchendu I, Hewitt-Taylor J, Turner-Wilson A, et al: Knowledge, attitudes, and perceptions about cervical cancer, and the uptake of cervical cancer screening in Nigeria: An integrative review. Sci Afr 14:e01013, 2021","journal-title":"Sci Afr"},{"key":"e_1_3_4_41_2","article-title":"Psycho-social factors influencing cervical cancer screening and human papilloma virus vaccination acceptance among female civil servants in Delta state, Nigeria","volume":"4","author":"Ohaeri B","year":"2018","unstructured":"Ohaeri B, Ebunu P, Ndikom C: Psycho-social factors influencing cervical cancer screening and human papilloma virus vaccination acceptance among female civil servants in Delta state, Nigeria. J Glob Oncol 4, 2018 (suppl 2; abstr 21s)","journal-title":"J Glob Oncol"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09479-7"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/0272684X20916611"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/10732748221130180"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-020-00324-5"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000479738.29076.94"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0551"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000431"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2020.100200"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140700"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3327"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00571-5"},{"key":"e_1_3_4_53_2","volume-title":"Protection from a Single Dose of HPV Vaccine: A major public health impact from IARC studies of vaccine efficacy (IARC Evidence Summary Briefs, No. 4)","author":"International Agency for Research on Cancer","year":"2023","unstructured":"International Agency for Research on Cancer: Protection from a Single Dose of HPV Vaccine: A major public health impact from IARC studies of vaccine efficacy (IARC Evidence Summary Briefs, No. 4). Lyon, France, International Agency for Research on Cancer, 2023. https:\/\/www.iarc.who.int\/featured-news\/protection-from-a-single-dose-of-hpv-vaccine\/"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00309-6"},{"key":"e_1_3_4_55_2","volume-title":"Human Papillomavirus (HPV)","author":"CDC","year":"2025","unstructured":"CDC: HPV vaccine recommendations. Human Papillomavirus (HPV), 2025. https:\/\/www.cdc.gov\/hpv\/hcp\/vaccination-considerations\/index.html"},{"key":"e_1_3_4_56_2","volume-title":"Human papillomavirus (HPV). The Australian Immunisation Handbook","author":"The Department of Health, Disability and Ageing","year":"2023","unstructured":"The Department of Health, Disability and Ageing: Human papillomavirus (HPV). The Australian Immunisation Handbook. Australian Government. 2023"},{"key":"e_1_3_4_57_2","unstructured":"Global adult tobacco survey in Nigeria: A success story in the African region. https:\/\/www.afro.who.int\/sites\/default\/files\/2017-09\/tob-gats-in-nigeria-a-sucess-story-in-afr.pdf"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2016.04.005"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1136\/tc.3.3.242"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1136\/tobaccocontrol-2011-050294"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199001113220205"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5829676"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12940-019-0490-6"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-023-01063-8"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","unstructured":"Ferguson J Alvarez A Mulligan M et al: A correction for Levin\u2019s formula in the presence of confounding. medRxiv 10.1101\/2023.02.02.23284941","DOI":"10.1101\/2023.02.02.23284941"}],"container-title":["JCO Global Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/GO-25-00318","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T18:33:05Z","timestamp":1772562785000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/GO-25-00318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1200\/GO-25-00318"],"URL":"https:\/\/doi.org\/10.1200\/go-25-00318","relation":{},"ISSN":["2687-8941"],"issn-type":[{"value":"2687-8941","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-06-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500318"}}